UNION therapeutics A/S
CVR 33963750 · Public limited company (A/S) · Active · Low risk
UNION therapeutics A/S is a Public limited company (A/S), founded on , based in Hellerup. The company is registered in the industry forskning og eksperimentel udvikling inden for naturvidenskab og teknik. Our model estimates a bankruptcy risk of 0.5% over the next 12 months, which is 0.4 times the average for Danish companies. 14 annual reports have been published, of which 2 more than six months after the end of the financial year. The latest annual report (31 Dec 2025) shows equity of DKK -147.7m and a net result of DKK -32.1m. CEO: Rasmus Vendler Toft-Kehler, Morten Otto Alexander Sommer.
Bankruptcy risk for UNION therapeutics A/S
0.4 × the average (1.41%) · higher risk than 60% of active Danish companies
Increases the risk
Reduces the risk
The factors show how often companies with the same characteristic went bankrupt compared with the average (“lift”). The risk is a statistical estimate from a model trained on 141,000+ Danish bankruptcies (AUC 0.93) – not a credit rating. Read about the method.
Company details
- CVR number
- 33963750
- Status
- Active
- Company type
- Public limited company (A/S)
- Founded
- (15 years)
- Address
- Tuborg Havnevej 18
2900 Hellerup - Municipality
- Gentofte
- Industry
- Forskning og eksperimentel udvikling inden for naturvidenskab og teknik (721000)
Bankruptcies in the industry: Anden forskning og eksperimentel udvikling inden for naturvidenskab og teknik - Share capital
- DKK 788k
- Employees
- 11 (2018)
- Auditor
- Beierholm Godkendt Revisionspartnerselskab
- Audit opted out
- No
Warning signs
| Annual reports filed late | 2 of 14 |
| Missing annual report | No |
| Negative equity | Yes |
| Equity ratio | -502.9% |
| Current ratio | 7% |
| Moves (last 2 years) | 0 |
| CEO changes in total | 5 |
| CEO's previous bankruptcies | 0 |
| Other companies at the address | 198 |
| Going-concern uncertainty | No |
Financials and key figures
| Financial year | 2025 | 2024 |
|---|---|---|
| Gross profit | DKK -11.8m | – |
| Net profit | DKK -32.1m | – |
| Equity | DKK -147.7m | – |
| Total assets | DKK 29.4m | – |
| Cash | DKK 6.7m | – |
| Short-term debt | DKK 177.0m | – |
| Avg. employees | 8 | – |
Latest annual report: Reporting class B · auditor's statement: Revisionspåtegning · Beierholm.
Filed annual reports
| Reporting period | Published | Days after period end | |
|---|---|---|---|
| 1 Jan 2025 – 31 Dec 2025 | 181 | ||
| 1 Jan 2024 – 31 Dec 2024 | 87 | ||
| 1 Jan 2023 – 31 Dec 2023 | 81 | ||
| 1 Jan 2022 – 31 Dec 2022 | 114 | ||
| 1 Jan 2021 – 31 Dec 2021 | 122 | ||
| 1 Jan 2020 – 31 Dec 2020 | 151 | ||
| 1 Jan 2019 – 31 Dec 2019 | 217 | Late | |
| 1 Jan 2018 – 31 Dec 2018 | 151 | ||
| 1 Jan 2017 – 31 Dec 2017 | 151 | ||
| 1 Jan 2016 – 31 Dec 2016 | 157 | ||
| 1 Jan 2015 – 31 Dec 2015 | 188 | Late | |
| 1 Jan 2014 – 31 Dec 2014 | 119 | ||
| 1 Jan 2013 – 31 Dec 2013 | 106 | ||
| 10 Oct 2011 – 31 Dec 2012 | 150 |
The annual report must reach the Danish Business Authority no later than 5 months after the end of the financial year. We mark reports published more than 6 months after as “late”.
Management, owners and auditor
| Role | Name | From | To |
|---|---|---|---|
| CEO | Rasmus Vendler Toft-Kehler | Current | |
| CEO | Morten Otto Alexander Sommer | Current | |
| CEO | Morten Otto Alexander Sommer | ||
| CEO | Morten Højland Boesen | ||
| Board | Rasmus Vendler Toft-Kehler | Current | |
| Board | Morten Otto Alexander Sommer | Current | |
| Board | Andrew John Oakley | Current | |
| Board | Stig Løkke Pedersen | Current | |
| Board | Peter Kristensen | Current | |
| Board | Astrid Sommer | ||
| Board | Anne Katrine Toft-Kehler | ||
| Board | Ole Skov | ||
| Board | Stig Løkke Pedersen | ||
| Board | Ole Skov | ||
| Board | Jutta Monika Heim | ||
| Board | Gitte Pugholm Aabo | ||
| Board | Arthur Joseph Higgins | ||
| Owner (5%) | EAF Procedius K/S | Current | |
| Owner (5%) | Pharmaway Invest ApS | Current | |
| Owner (5%) | T&W HOLDING A/S | Current | |
| Owner (20%) | MANJIN ApS | Current | |
| Owner (20%) | VENDLER ApS | Current | |
| Owner (50%) | MANJIN ApS | ||
| Owner (50%) | VENDLER ApS | ||
| Owner (25%) | MANJIN ApS | ||
| Owner (25%) | VENDLER ApS | ||
| Owner (5%) | T&W HOLDING A/S | ||
| Owner (20%) | MANJIN ApS | ||
| Owner (20%) | VENDLER ApS | ||
| Owner (20%) | Vendler Alpha ApS | ||
| Owner (20%) | Manjin Holding ApS | ||
| Auditor | Beierholm Godkendt Revisionspartnerselskab | Current | |
| Auditor | Selskabet af den 4. juli 2016 RVT ApS | ||
| Auditor | Datoselskabet af den 3. juli 2016 RVT P/S | ||
| Auditor | EY Godkendt Revisionspartnerselskab | ||
| Founder | MANJIN ApS | Current | |
| Founder | VENDLER ApS | Current |
The CEOs' other companies
Rasmus Vendler Toft-Kehler – 5 other companies
- Clinical-Microbiomics A/S Active
- GRIT A/S Opløst
- Matr Foods ApS Active
- VENDLER ApS Active
- Vendler Alpha ApS Opløst
Morten Otto Alexander Sommer – 11 other companies, of which 1 bankrupt
- HEED DIAGNOSTICS ApS Bankrupt 15 Apr 2016
- BIOSYNTIA ApS Active
- Clinical-Microbiomics A/S Active
- FORMBION ApS Opløst
- MANJIN ApS Active
- MICROLYTIC ApS Opløst
- Manjin Holding ApS Opløst
- NOVOZYMES A/S Active
- PALSGAARD GODS A/S Active
- SNIPR Biome ApS Active
- SNIPR Holdings ApS Active
Morten Højland Boesen – 5 other companies
- EMAI Invest ApS Active
- Qufora A/S Active
- Qufora Denmark ApS Active
- Qufora Holding ApS Active
- UNION therapeutics Research Services ApS Opløst
Address history (4 moves)
| Tuborg Havnevej 18, 2900 Hellerup | |
| Kemitorvet 220, 2800 Kgs. Lyngby | |
| Kogle Alle 5, 2970 Hørsholm | |
| c/o Danmarks Tekniske Universitet, Matematiktorvet 301, 2800 Kgs. Lyngby | |
| c/o Rasmus Vendler Toft, Galionsvej 1, 2. 32, 1437 København K |
Former names
| UNION therapeutics A/S | – now |
| AntibioTx A/S | – |
| ANTIBIOTX ApS | – |
| SYNERCURE ApS | – |
Employees per year
Other companies at the same address
- AMIRAL HOLDINGS A/S Bankrupt
- CING STARS ApS Bankrupt
- DEPA EUROPE GROUP ApS Bankrupt
- DS 1516 ApS Bankrupt
- ESV A/S Bankrupt
- GLOBAL OIL SECURITY ApS Bankrupt
- GREAT DANE INTERNATIONAL ApS Bankrupt
- HANDYBULK INVEST ApS Bankrupt
- ID SHIPPING A/S Bankrupt
- INVESTERINGSGRUPPEN DANMARK A/S Bankrupt
- NPC Projects A/S Bankrupt
- SCSK 6313 ApS Bankrupt
- SPS HOLDING A/S Bankrupt
- AKTIESELSKABET AF 1. MARTS 2003 Opløst
- AMALIEGADE 22 A/S Opløst
- ASX NR. 13.120 ApS Opløst
- ATLANTIC INVEST A/S Active
- Acount Technologies ApS Active
- Atlantic Invest Holding ApS Active
- Atlantic Invest NewCo ApS Fusioneret
- Atlantic Invest PE ApS Active
- B-SHIPPING ApS Fusioneret
- B-SHIPPING ApS Fusioneret
- BIANCO REDERI ApS Fusioneret
- BICO 2018 ApS Opløst
Similar companies in Gentofte
- SNL BioSolutions ApS Hellerup
- NIVI Development A/S Hellerup
- Neo Biopharm ApS Hellerup
- G2B BioSolutions ApS Hellerup
- Beatsco2 ApS Charlottenlund
- MHJ Research ApS Hellerup
- XY Therapeutics ApS Charlottenlund
- Lophora ApS Charlottenlund
- CABA APS Charlottenlund
- Devopharma ApS Charlottenlund
- C- ApS Hellerup
- Aktieselskabet af 1. juni 2011 II Hellerup
Questions and answers about UNION therapeutics A/S
Has UNION therapeutics A/S gone bankrupt?
No, UNION therapeutics A/S is not registered as bankrupt in the CVR register. Its status is: active.
What is the bankruptcy risk of UNION therapeutics A/S?
Our model estimates a bankruptcy risk of 0.5% over the next 12 months (low risk), which is 0.4 times the average for Danish companies.
Who is the CEO of UNION therapeutics A/S?
Rasmus Vendler Toft-Kehler, Morten Otto Alexander Sommer are the CEOs of UNION therapeutics A/S.
Who is the auditor of UNION therapeutics A/S?
UNION therapeutics A/S most recently used Beierholm Godkendt Revisionspartnerselskab.
When was UNION therapeutics A/S founded?
UNION therapeutics A/S was founded on 10 October 2011.
What is the equity of UNION therapeutics A/S?
Equity was DKK -147.7m according to the annual report for the period ending 31 December 2025.
Source: the CVR register and annual reports published by the Danish Business Authority. The information is updated continuously.